227 related articles for article (PubMed ID: 10196303)
1. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.
Zafrullah M; Ozdener MH; Kumar R; Panda SK; Jameel S
J Virol; 1999 May; 73(5):4074-82. PubMed ID: 10196303
[TBL] [Abstract][Full Text] [Related]
2. Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells.
Torresi J; Li F; Locarnini SA; Anderson DA
J Gen Virol; 1999 May; 80 ( Pt 5)():1185-1188. PubMed ID: 10355765
[TBL] [Abstract][Full Text] [Related]
3. Expression in animal cells and characterization of the hepatitis E virus structural proteins.
Jameel S; Zafrullah M; Ozdener MH; Panda SK
J Virol; 1996 Jan; 70(1):207-16. PubMed ID: 8523527
[TBL] [Abstract][Full Text] [Related]
4. [Interface domain of hepatitis E virus capsid protein homodimer].
Li SW; He ZQ; Wang YB; Chen YX; Liu RS; Lin J; Gu Y; Zhang J; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):90-8. PubMed ID: 16108497
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein.
Paliwal D; Panda SK; Kapur N; Varma SPK; Durgapal H
J Gen Virol; 2014 Aug; 95(Pt 8):1689-1700. PubMed ID: 24795447
[TBL] [Abstract][Full Text] [Related]
6. The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA.
Surjit M; Jameel S; Lal SK
J Virol; 2004 Jan; 78(1):320-8. PubMed ID: 14671114
[TBL] [Abstract][Full Text] [Related]
7. The full-length and N-terminal deletion of ORF2 protein of hepatitis E virus can dimerize.
Tyagi S; Jameel S; Lal SK
Biochem Biophys Res Commun; 2001 Aug; 286(1):214-21. PubMed ID: 11485331
[TBL] [Abstract][Full Text] [Related]
8. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2.
Tyagi S; Korkaya H; Zafrullah M; Jameel S; Lal SK
J Biol Chem; 2002 Jun; 277(25):22759-67. PubMed ID: 11934888
[TBL] [Abstract][Full Text] [Related]
9. The effect of antigen targeting sequences on antibody responses to hepatitis E virus DNA vaccines in rats and sheep.
Li F; Loke P; Healy A; Lightowlers MW; Gauci CG; Purcell DF; Anderson DA
Vaccine; 2006 Feb; 24(9):1367-77. PubMed ID: 16242219
[TBL] [Abstract][Full Text] [Related]
10. Retention by the endoplasmic reticulum of rotavirus VP7 is controlled by three adjacent amino-terminal residues.
Maass DR; Atkinson PH
J Virol; 1994 Jan; 68(1):366-78. PubMed ID: 8254749
[TBL] [Abstract][Full Text] [Related]
11. New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle.
Ankavay M; Montpellier C; Sayed IM; Saliou JM; Wychowski C; Saas L; Duvet S; Aliouat-Denis CM; Farhat R; de Masson d'Autume V; Meuleman P; Dubuisson J; Cocquerel L
Sci Rep; 2019 Apr; 9(1):6243. PubMed ID: 31000788
[TBL] [Abstract][Full Text] [Related]
12. Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus.
Zafrullah M; Khursheed Z; Yadav S; Sahgal D; Jameel S; Ahmad F
Biochem Biophys Res Commun; 2004 Jan; 313(1):67-73. PubMed ID: 14672699
[TBL] [Abstract][Full Text] [Related]
13. Sequences in rotavirus glycoprotein VP7 that mediate delayed translocation and retention of the protein in the endoplasmic reticulum.
Stirzaker SC; Poncet D; Both GW
J Cell Biol; 1990 Oct; 111(4):1343-50. PubMed ID: 2170420
[TBL] [Abstract][Full Text] [Related]
14. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
15. Role of asparagine at position 562 in dimerization and immunogenicity of the hepatitis E virus capsid protein.
Xu M; Behloul N; Wen J; Zhang J; Meng J
Infect Genet Evol; 2016 Jan; 37():99-107. PubMed ID: 26584510
[TBL] [Abstract][Full Text] [Related]
16. Identification of Plant Peptides as Novel Inhibitors of Orthohepevirus A (HEV) Capsid Protein by Virtual Screening.
Mustafa G; Mahrosh HS; Attique SA; Arif R; Farah MA; Al-Anazi KM; Ali S
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985647
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.
Kalia M; Chandra V; Rahman SA; Sehgal D; Jameel S
J Virol; 2009 Dec; 83(24):12714-24. PubMed ID: 19812150
[TBL] [Abstract][Full Text] [Related]
18. The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus.
Haqshenas G; Huang FF; Fenaux M; Guenette DK; Pierson FW; Larsen CT; Shivaprasad HL; Toth TE; Meng XJ
J Gen Virol; 2002 Sep; 83(Pt 9):2201-2209. PubMed ID: 12185274
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
